Recce Pharmaceuticals Secures Global Patent Portfolio
Recce Pharmaceuticals CEO discusses the formal granting of a new patent by the China National Intellectual Property Administration, securing global patent protection in major pharmaceutical markets.
The formal granting of the new patent by the China National Intellectual Property Administration is a significant milestone for Recce Pharmaceuticals, ensuring patent protection in major global pharmaceutical markets. This news highlights the company's commitment to innovation in the treatment of common human infections, impacting the pharmaceutical industry and potential future healthcare solutions.
